Evidence map›Paper›PMID 37550058›Full record

ArticleeNeuro2023

Reelin Rescues Behavioral, Electrophysiological, and Molecular Metrics of a Chronic Stress Phenotype in a Similar Manner to Ketamine.

Jenessa N Johnston, Josh Allen, Irene Shkolnikov, Carla L Sanchez-Lafuente, Brady S Reive, Kaylene Scheil, Stanley Liang, Brian R Christie, Lisa E Kalynchuk, Hector J Caruncho

Open access · goldAbstract read
In one paragraph

Article in eNeuro, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Ketamine induced synaptic plasticity operates independently of long-term potentiation.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jenessa N JohnstonDivision of Medical Sciences, University of Victoria, Victoria, British Columbia V8P 5C2, Canada jenessaj@uvic.ca hectorjcaruncho@uvic.ca.ORCID 0000-0003-2986-3179
Josh AllenDivision of Medical Sciences, University of Victoria, Victoria, British Columbia V8P 5C2, Canada.
Irene ShkolnikovDivision of Medical Sciences, University of Victoria, Victoria, British Columbia V8P 5C2, Canada.
Carla L Sanchez-LafuenteDivision of Medical Sciences, University of Victoria, Victoria, British Columbia V8P 5C2, Canada.
Brady S ReiveDivision of Medical Sciences, University of Victoria, Victoria, British Columbia V8P 5C2, Canada.ORCID 0000-0001-5208-6051
Kaylene ScheilDivision of Medical Sciences, University of Victoria, Victoria, British Columbia V8P 5C2, Canada.
Stanley LiangDivision of Medical Sciences, University of Victoria, Victoria, British Columbia V8P 5C2, Canada.
Brian R ChristieDivision of Medical Sciences, University of Victoria, Victoria, British Columbia V8P 5C2, Canada.ORCID 0000-0002-6830-0160
Lisa E KalynchukDivision of Medical Sciences, University of Victoria, Victoria, British Columbia V8P 5C2, Canada.
Hector J CarunchoDivision of Medical Sciences, University of Victoria, Victoria, British Columbia V8P 5C2, Canada jenessaj@uvic.ca hectorjcaruncho@uvic.ca.
University of Victoria · CA

Funding

CIHR
6 · The paper itself

Abstract

Over the past decade, ketamine, an NMDA receptor antagonist, has demonstrated fast-acting antidepressant effects previously unseen with monoaminergic-based therapeutics. Concerns regarding psychotomimetic effects limit the use of ketamine for certain patient populations. Reelin, an extracellular matrix glycoprotein, has shown promise as a putative fast-acting antidepressant in a model of chronic stress. However, research has not yet demonstrated the changes that occur rapidly after peripheral reelin administration. To address this key gap in knowledge, male Long-Evans rats underwent a chronic corticosterone (CORT; or vehicle) paradigm (40 mg/kg, 21 d). On day 21, rats were then administered an acute dose of ketamine (10 mg/kg, i.p.), reelin (3 µg, i.v.), or vehicle. Twenty-four hours after administration, rats underwent behavioral or

Indexed as

KetamineAnimalsAntidepressive AgentsCorticosteroneDepressionHippocampusMaleRatsRats, Long-EvansAntidepressive AgentsCorticosteroneKetaminecorticosteronedepressionketaminelong-term potentiationreelinsynaptic plasticity

Identifiers

PMID37550058
PMCPMC10431216
OpenAlexW4385622232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.